Untangling the Immunological Implications of Nadir on CD4+ Cell Recovery during Suppressive Highly Active Antiretroviral Therapy

This publication has 10 references indexed in Scilit:

• Common γ chain cytokines: Dissidence in the details
  Immunology Letters, 2007
• CD4+ Cell Count 6 Years after Commencement of Highly Active Antiretroviral Therapy in Persons with Sustained Virologic Suppression
  Clinical Infectious Diseases, 2007
• Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
  AIDS, 2006
• Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy
  Clinical Infectious Diseases, 2005
• Mechanisms Involved in the Low‐Level Regeneration of CD4⁺Cells in HIV‐1–Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads
  The Journal of Infectious Diseases, 2005
• Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study
  HIV Medicine, 2003
• Incomplete CD4 T Cell Recovery in HIV-1 Infection After 12 Months of Highly Active Antiretroviral Therapy Is Associated With Ongoing Increased CD4 T Cell Activation and Turnover
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
  The Lancet, 2002
• Interleukin-7: from bench to clinic
  Blood, 2002
• Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas
  Archives of internal medicine (1960), 1974